The problem isn't with what we don't know, the problem is with what we do know that isn't so.
vative research in hydrocephalus, we have formulated 10 questions that we believe reflect critical gaps in our knowledge of hydrocephalus. Rigorous answers to these questions would produce important gains in our understanding of this condition that could lead to more effective and reliable treatment.
Question 1: How Do We Define Hydrocephalus?
A rigorous definition of hydrocephalus is surprisingly difficult and is becoming more complicated. From a physiological perspective, the finding of enlarged ventricles combined with high ICP represents only one presentation along a spectrum of disorders ranging from pseudotumor cerebri to low-pressure hydrocephalus. From a clinical perspective, how should we classify patients with hydrocephalus, from truly asymptomatic to severely impaired individuals, and how do we measure recovery after treatment? From the anatomical perspective, given the success of endoscopic third ventriculostomy in patients with communicating hydrocephalus and shunt failure, does the concept of obstructive versus "communicating" hydrocephalus need to be reassessed? Most surgeons do not question the dogma that hydrocephalus is caused by the mechanical obstruction of the absorption of CSF through the arachnoid villi, although there is considerable evidence that the arachnoid villi are not the principal sites of CSF absorption at normal CSF pressures. 1, 8, 17 Do lymphatic or vascular pathways mediate CSF absorption? If CSF water can move freely, and bidirectionally across brain capillary membranes, is it time to reconsider the concept of CSF "absorption?" 9, 10 If we are to make progress, we must be willing to expand into an exciting, albeit more complex, scientific frontier of CSF physiology that relies less on bulk flow and more heavily on intimate relationships between pulsatile CSF and blood movement within the intracranial compartment.
Question 3: Why Do the Ventricles Dilate in
Communicating Hydrocephalus?
The question asked by Dandy and Blackfan 3 in 1914, and reiterated many times by others, has still not been answered: how can the ventricles dilate and the subarachnoid spaces be compressed when the subarachnoid and the ventricular CSF are in free communication? A static pressure gradient in communicating hydrocephalus would seem to violate the Pascal law. Fundamentally, do we understand the pathophysiology of communicating hydrocephalus as well as we think we do?
Question 4: What Happens to the Structure and Function of the Brain When It Is Compressed and Stretched by the Expanding Ventricles?
Why does the cortical mantle reexpand in most but not all patients when ventricular volume is reduced? Is brain reexpansion necessary for all patients to be successfully treated? And why do some patients with untreated hydrocephalus appear to have no neurological impairment? Although more details of the cellular pathology associated with hydrocephalus have been forthcoming, 5, 6 a true understanding of injury mechanisms, their multiple interactions, and the role of neural plasticity has escaped us. Thus, the reasons for reconstitution of the cortical mantle are still not clear. By gaining a complete understanding of the cellular basis for cortical reexpansion, we will no doubt discover many of the fundamental mechanisms that put the hydrocephalic brain at risk and provide the basis for recovery.
Question 5: What Is the Role of Cerebrovenous Pressure in Hydrocephalus?
Increased cerebrovenous pressure has been found in virtually all clinical and experimental studies of hydrocephalus, and cerebrovenous hypertension also plays a role in pseudotumor cerebri. Nevertheless, displacement of venous blood is the main source of rapid compliance in the craniospinal axis in response to expanding masses or hydrocephalus. The role and interactions of cerebrovenous pressure and blood volume in ICP pathophysiology and intractable shunt problems deserve further investigation.
Question 6: What Causes NPH?
It is not clear whether idiopathic NPH shares a common pathophysiology with secondary communicating hydrocephalus of known causes. Can the cause or causes of idiopathic NPH be discovered, and thus prevented? Are there critical relationships between NPH, degenerative dementias, and subcortical ischemic vascular disease, and how do they influence clinical presentation and outcomes? Understanding the cause of NPH may lead to preventive measures, risk factor-based screening, and better diagnostic tools and clinical outcomes.
Question 7: What Causes Low-Pressure
Hydrocephalus?
Low-pressure hydrocephalus is an enigma. A clear view of this perplexing condition, in which patients with ventriculomegaly show symptoms of hydrocephalus and even signs of brain herniation despite zero or negative ICP, may provide a much deeper understanding of hydrocephalus.
Question 8: What Is the Pathophysiology of SVS?
Shunt overdrainage continues despite various valve designs specifically aimed to prevent it, 14 and clinical experience suggests that the symptoms of SVS do not correlate with ICP. 11 Furthermore, why does SVS appear to be associated only with shunts placed in infancy, whereas small ventricles can develop in adults with shunt-treated hydrocephalus who do not have symptoms of SVS? The clinical presentation of hydrocephalus differs with age.
2 Does this fact reflect different susceptibility and compensatory mechanisms that depend on the age and developmental or involutional status of the brain? Now that more and more children with hydrocephalus are becoming adults with hydrocephalus, their medical care requires a better understanding of the plasticity and age-related changes that accompany chronic hydrocephalus. The medical treatment also requires a change in the organization of healthcare services provided by neurosurgeons and neurologists so that the needs of adults with hydrocephalus can be met.
Conclusions
There are, of course, many other important questions, and this is not to say that we have not come a long way in research of hydrocephalus during the last 75 years. Nonetheless, our understanding of hydrocephalus is not nearly as sophisticated or complete as we might have imagined. Fifty years after the introduction of shunts for the treatment of this previously untreatable disorder, we must acknowledge that the shunt is not a cure for hydrocephalus; it is only a "patch," and an unreliable one at that. We know a lot about hydrocephalus, but much of what is true about hydrocephalus is strange, and is not necessarily the same as what we think we know. There is surprisingly little scientific basis for many of our commonly held opinions.
Our intent is to instigate a new and vigorous dialogue among neurosurgeons, neurologists, neuroscientists, and research funding agencies that will promote needed advancements in the understanding of hydrocephalus. The recent symposium "Hydrocephalus: Myths, New Facts, Clear Directions," sponsored by the National Institutes of Health (Bethesda, MD, September 29-October 1, 2005), underscores the need for this dialogue.
It is time to dispense with our presuppositions, to be clear about what we do and do not know, to ask the basic questions again, and to follow confidently where the answers lead us.
